Vendor Selection Program
Wednesday, September 16, 2009 - Day 3
| Track A |
|---|
|
2:00 - 3:00
Int’l Project Teams: Communication, Culture, Personalities, Language, Distance
Gregory P. Bello
Director, API Sourcing
Alpharma Animal Health
Brian S. Bronk, Ph.D.
Vice President of Chemistry
Satori Pharmaceuticals Inc.
Arvind Mathur, Ph.D.
Associate Director, Drug Discovery Chemistry
Bristol-Myers Squibb
Diane McGuire
Principal
PharmAcumen Consulting
Stuart Needleman
President, API Development and Manufacturing
Aptuit
Chitra Sharma
Principal
CMC Consultant
|
| Track B |
|---|
|
3:00 - 4:00
Early Stage API Outsourcing and Vendor Management
Hui-Yin (Harry) Li, Ph.D.
President
Wilmington PharmaTech
Michael Semo
Sourcing Manager / Virtual CMC Team
Eli Lilly & Company
Bharat Shah, Ph.D.
President
Calyx Chemicals and Pharmaceuticals
Richard Toupence
Process Research Sourcing
Merck & Company
Paul F. Vogt, Ph.D.
Vice President, Process Development Services
SiGNa Chemistry, Inc.
|
| Track C |
|---|
|
1:00 - 2:00
How Can Suppliers Get Selected? Or De-Selected?
Balreddy Kamireddy, Ph.D.
CRO and Synthesis Research Leader
DuPont Crop Protection
Balaram Patro, Ph.D.
VP and Head of Medicinal Chemstry
GVK Biosciences
Scott Powers
Business Development Manager
BASF Custom Synthesis
Mark Ralph, Ph.D.
Manager, Medicinal Chemistry
Boehringer Ingelheim
Richard Toupence
Process Research Sourcing
Merck & Company
|
| Track D |
|---|
|
2:00 - 3:00
Supplier Performance Metrics and Partner Relationship Management
Firoz D. Antia, Ph.D.
Executive Director Product Development
Palatin Technologies, Inc.
Ellen Crawford
Strategic External Resourcing
Novartis Institutes for BioMedical Research, Inc.
Mark Eugenio
Director of Commercial Development
CML
Stuart Hadley
Outsourcing Project Manager
AstraZeneca
Brian Scanlon
Vice President
Cambridge Major Laboratories
Richard D. Wilson, Ph.D.
Associate Director, Medicinal Chemistry
Theravance, Inc.
|
|
3:00 - 4:00
Small Molecule Bio-Tech Vendor Selection Criteria
Stuart Levy, Ph.D.
Principal
SGL Chemistry Consulting
Stuart Needleman
President, API Development and Manufacturing
Aptuit
Silvina Garcia Rubio, Ph.D.
Senior Director, Technical Affairs
Helsinn Therapeutics US, Inc.
Shuguang Zhu, Ph.D.
President
Apincon
|